We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Disease modification in inflammatory skin disorders: opportunities and challenges

    Progress in understanding of the mechanisms underlying chronic inflammatory skin disorders, such as atopic dermatitis and psoriasis vulgaris, has led...

    Article 13 July 2023
  2. Comparative efficacy of surgical approaches to disease modification in Parkinson disease

    Parkinson’s disease (PD) may optimally be treated with a disease-modifying therapy to slow progression. We compare data underlying surgical...

    Shervin Rahimpour, Su-Chun Zhang, ... Dennis A. Turner in npj Parkinson's Disease
    Article Open access 25 March 2022
  3. ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification

    Angiotensin-converting enzyme 2 (ACE2), a counter regulator of the renin-angiotensin system, provides protection against several chronic diseases....

    Chia-Wen Wang, Huai-Chia Chuang, Tse-Hua Tan in Journal of Biomedical Science
    Article Open access 22 August 2023
  4. Prodromal Parkinson's disease: hype or hope for disease-modification trials?

    The ultimate goal in Parkinson's disease (PD) research remains the identification of treatments that are capable of slowing or even halting the...

    Philipp Mahlknecht, Kathrin Marini, ... Klaus Seppi in Translational Neurodegeneration
    Article Open access 21 February 2022
  5. Lactylation: the novel histone modification influence on gene expression, protein function, and disease

    Lactic acid, traditionally considered as a metabolic waste product arising from glycolysis, has undergone a resurgence in scientific interest since...

    Yue Hu, Zhenglin He, ... **anling Cong in Clinical Epigenetics
    Article Open access 29 May 2024
  6. In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification

    Neurodegenerative diseases (NDDs), including AD, PD, HD, and ALS, represent a growing public health concern linked to aging and lifestyle factors,...

    Pouya Ebrahimi, Elham Davoudi, ... Issa Sadeghian in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 22 May 2024
  7. Emerging role of protein modification in inflammatory bowel disease

    The onset of inflammatory bowel disease (IBD) involves many factors, including environmental parameters, microorganisms, and the immune system....

    Gaoying Wang, **tao Yuan, ... Fei Mao in Journal of Zhejiang University-SCIENCE B
    Article 17 March 2022
  8. Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies

    Tau, a microtubule-associated protein predominantly localized in neuronal axons, plays a crucial role in promoting microtubule assembly, stabilizing...

    Jie Yang, Naiting Shen, ... Hong-Lian Li in Molecular Neurobiology
    Article Open access 20 December 2023
  9. Nucleic acid and protein methylation modification in renal diseases

    Although great efforts have been made to elucidate the pathological mechanisms of renal diseases and potential prevention and treatment targets that...

    Juan **, Xue-mei Liu, ... **ao-ming Meng in Acta Pharmacologica Sinica
    Article 15 December 2023
  10. New horizons for the role of RNA N6-methyladenosine modification in hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) is one of the most common malignancy, presenting a formidable challenge to the medical community owing to its...

    Yu-jia Li, Yang-ling Qiu, ... Shi-zhong Zheng in Acta Pharmacologica Sinica
    Article 09 January 2024
  11. Targeted genome-modification tools and their advanced applications in crop breeding

    Crop improvement by genome editing involves the targeted alteration of genes to improve plant traits, such as stress tolerance, disease resistance or...

    Boshu Li, Chao Sun, ... Caixia Gao in Nature Reviews Genetics
    Article 24 April 2024
  12. Oligonucleotide therapeutics and their chemical modification strategies for clinical applications

    Background

    Oligonucleotide therapeutics have emerged as a promising and dynamic class of pharmaceutical agents with remarkable potential for treating...

    Hyunsook Kim, Sujeong Kim, ... Hyuk** Lee in Journal of Pharmaceutical Investigation
    Article 29 February 2024
  13. The role of N-methyladenosine modification in acute and chronic kidney diseases

    N 6-methyladenosine (m6A) modification is a kind of RNA modification in which methylation occurs at the sixth N position in adenosine in RNA, which...

    Saiqi Qi, Jie Song, ... Huachun Weng in Molecular Medicine
    Article Open access 08 December 2023
  14. RNA modification: mechanisms and therapeutic targets

    RNA modifications are dynamic and reversible chemical modifications on substrate RNA that are regulated by specific modifying enzymes. They play...

    Lei Qiu, Qian **g, ... Junhong Han in Molecular Biomedicine
    Article Open access 24 August 2023
  15. Disease Modification in Epilepsy: Behavioural Accompaniments

    According to the definition of epileptogenesis, “disease modification” refers to every clinically relevant therapeutic outcome which does not...
    Emilio Russo, Rita Citraro in Psychiatric and Behavioral Aspects of Epilepsy
    Chapter 2021
  16. Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach

    This book reviews the potential effect of diet modification, lipids, and carbohydrate consumptions, vitamin supplementation, antioxidants, and...

    Arokiyasamy Justin Thenmozhi, Thamilarasan Manivasagam in Nutritional Neurosciences
    Book 2023
  17. Histone modification in podocyte injury of diabetic nephropathy

    Diabetic nephropathy (DN), an important complication of diabetic microvascular disease, is one of the leading causes of end-stage renal disease...

    Simeng Wang, **nyu Zhang, ... Rong Wang in Journal of Molecular Medicine
    Article 30 August 2022
  18. Emerging role of RNA modification and long noncoding RNA interaction in cancer

    RNA modification, especially N6-methyladenosine, 5-methylcytosine, and N7-methylguanosine methylation, participates in the occurrence and progression...

    Liqiong Yang, Lu Tang, ... **g Shen in Cancer Gene Therapy
    Article Open access 14 February 2024
  19. Survey of attitude to human genome modification in Nigeria

    Gene editing and mitochondrial replacement therapy (MRT) are biotechnologies used to modify the host nuclear and mitochondrial DNA, respectively....

    Maryam Jibrilla, Hayatu Raji, Malachy Ifeanyi Okeke in Journal of Community Genetics
    Article 23 November 2023
  20. Epigenetic Modification in Aluminum-Induced Neurotoxicity

    The toxicity of aluminum has been confirmed from many aspects, such as plant, animal, model organism, in vitro study, and epidemiological studies....
    Qiao Niu, Ruifeng Liang in Neurotoxicity of Aluminum
    Chapter 2023
Did you find what you were looking for? Share feedback.